SEATTLE, WA July 29, 2019 — Cyrus Biotechnology, Inc., a Seattle-based biotech software company commercializing Rosetta, the most advanced computational protein design platform, has been mentioned in the BIOCENTURY’s article: Institute for Protein Design’s de novo revolution – How a Seattle hub is overhauling protein- and cell-based therapies by breaking free o evolution’s constraints. The […]

SEATTLE, WA May 29, 2019 — Cyrus Biotechnology, Inc., a Seattle-based biotech software company commercializing Rosetta, the most advanced computational protein design platform, is announcing the release of novel software capabilities to handle protein interactions with DNA & RNA as part of its Cyrus Bench® platform. “Proteins that interact directly with DNA and RNA are […]